Perbedaan Informasi Teknologi Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Informasi Teknologi Indonesia Tbk. diperdagangkan di Rp111 (kapitalisasi pasar 365,4 M, volume 24 jam 13,91 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Informasi Teknologi Indonesia Tbk. jauh lebih besar — sekitar 3,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JATI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 365,4 M | 104,4 M |
Volume | 13,91 jt | — |
Lot | 139,12 rb | — |
Perputaran | 1,54 M | — |
Harga Rata-rata | 110,85 | — |
Nilai Transaksi | 1,54 M | — |
Harga Ekuilibrium Indikatif | 111 | — |
Volume Ekuilibrium Indikatif | 339 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Informasi Teknologi Indonesia Tbk (the “Company”) was established based on Deed No. 127 dated April 11, 2002 of Iman Immanuel Sinaga, S.H., CN, a substitute notary of Dr. Irawan Soerodjo, S.H., M,S.i. The Company started its commercial operations in 2002. The direct parent entity and ultimate parent entity of the Company are PT Jati Piranti Solusindo and PT Indivara Sejahtera Mandiri.
Selengkapnya di halaman JATI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →